Latest

Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆

Updated 27 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Leicester

← All UK trials

The most recently updated industry-sponsored clinical trials recruiting across the United Kingdom — searchable by condition, sponsor, phase and city. Refreshed daily from the ClinicalTrials.gov registry.

11

Recruiting now

17

Studies tracked

Leicester

Selected city

Recruiting Phase 2/Phase 3

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease

Proteinuric Kidney Disease
Vertex Pharmaceuticals Incorporated · started 2022-03-30

📍 Basildon · Bellshill · Birmingham · Carshalton · Leicester

NCT05312879 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
Lexicon Pharmaceuticals · started 2024-09-24

📍 Glasgow · Leicester · Liverpool · London

NCT06481891 on ClinicalTrials.gov ↗

Recruiting Phase 2

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
Contineum Therapeutics · started 2026-01-08

📍 Leicester · London · Southampton · Edinburgh · Perth

NCT07284459 on ClinicalTrials.gov ↗

Active Phase 2

A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer

Advanced ER-Positive HER2-Negative Breast Cancer
AstraZeneca · started 2020-04-22

📍 Derby · Leicester

NCT04214288 on ClinicalTrials.gov ↗

Recruiting

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Refractory Angina
Shockwave Medical, Inc. · started 2022-01-04

📍 Basildon · Birmingham · Bristol · Cambridge · Dorchester

NCT05102019 on ClinicalTrials.gov ↗

Active Phase 3

Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia
Acerta Pharma BV · started 2015-07-28

📍 Birmingham · Bournemouth · Cambridge · Cardiff · Greater London

NCT02477696 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

Rheumatoid Arthritis
Hoffmann-La Roche · started 2025-12-05

📍 Leicester · Doncaster · Newcastle upon Tyne · Barnet

NCT07137598 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Bristol-Myers Squibb · started 2026-01-02

📍 Leicester · London

NCT07063745 on ClinicalTrials.gov ↗

Active Phase 3

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

Chronic Lymphocytic Leukemia
Acerta Pharma BV · started 2015-06-26

📍 Bournemouth · Cambridge · Leeds · Leicester · London

NCT02475681 on ClinicalTrials.gov ↗

Active Phase 4

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

Asthma
AstraZeneca · started 2019-10-08

📍 Cambridge · Headington · Leicester · Liverpool · London

NCT03953300 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Mirati Therapeutics Inc. · started 2020-12-02

📍 Birmingham · Edinburgh · Kent · Leicester · London

NCT04613596 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy

Chronic Graft-versus-host-disease
Incyte Corporation · started 2025-06-04

📍 Cardiff · Glasgow · Leeds · Leicester · London

NCT06821542 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Myelofibrosis, Anemia
Takeda · started 2026-09-02

📍 Lincoln · Leicester · London · Sunderland · Birmingham

NCT07623161 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration
EyeBiotech Ltd. · started 2026-03-27

📍 Leicester · London

NCT07440225 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC · started 2025-06-30

📍 London · Dundee · Huddersfield · Colchester · Orpington

NCT06966700 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Breast Neoplasms
Merck Sharp & Dohme LLC · started 2025-07-21

📍 London · Leicester · Manchester

NCT07060807 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Merck Sharp & Dohme LLC · started 2025-04-09

📍 Cambridge · Edinburgh · Preston · London · Sutton

NCT06824467 on ClinicalTrials.gov ↗

No trials match your search.

Browse by city

London · 115 Manchester · 41 Cambridge · 34 Birmingham · 30 Glasgow · 25 Oxford · 24 Edinburgh · 20 Sheffield · 20 Leicester · 17 Newcastle upon Tyne · 15 Bristol · 15 Liverpool · 14 Leeds · 13 Southampton · 13 Cardiff · 12 Sutton · 11

Browse by condition

Chronic Lymphocytic Leukemia · 4 Colitis, Ulcerative · 3 Non-small Cell Lung Cancer · 3 Carcinoma, Non-Small-Cell Lung · 3 Breast Cancer · 3 Crohn's Disease · 3 Rheumatoid Arthritis · 2 Hypertension · 2 Alzheimer Disease · 2 Age-Related Macular Degeneration · 2 Prostatic Neoplasms · 2 Type 1 Diabetes · 2 Major Depressive Disorder (MDD) · 2 Idiopathic Pulmonary Fibrosis · 2 Chronic Inflammatory Demyelinatin… · 2 Amyotrophic Lateral Sclerosis · 2

Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/leicester (Accessed: 27 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.